The industrial revolution was sparked by James Watt’s steam engine, which unleashed the power of machinery and transformed human history. Now, as we are swept up in the momentum of the digital wave, we are ushering in the “Fourth Industrial Revolution.” According to Zheng Yuguo, an academician at the Chinese Academy of Engineering, this transformation is driven by breakthroughs in artificial intelligence, biotechnology, and other cutting-edge fields. Synthetic biomanufacturing is playing a crucial role in reshaping industrial production paradigms.
The Core of the Fourth Industrial Revolution
The first industrial revolution was characterized by the adoption of steam power; the second, by electrification; and the third, by atomic energy and computers. While the third revolution is still unfolding, the fourth is already underway. It is marked by artificial intelligence, new materials, molecular engineering, virtual reality, quantum information, and biotechnology. Its essence lies in enhancing resource productivity, reducing pollution, and transforming lifestyles.
At the heart of this revolution is synthetic biomanufacturing, an interdisciplinary field that applies engineering principles to design, modify, or reconstruct biological systems. By reprogramming cellular machinery, scientists can precisely and efficiently synthesize target molecules, thereby revolutionizing traditional manufacturing processes.
Transforming Fine Chemical Industries
Synthetic biomanufacturing is driving a paradigm shift in various industries, including pharmaceuticals, agrochemicals, food production, and materials science. Compared to traditional petrochemical processes, bio-based production methods can reduce energy consumption by 30-50%, with the potential to reach 50-70% in the future. One example is replacing traditional metal catalysts with enzyme-based systems. Take, for instance, nitrile hydratase for acrylamide production. This technology, pioneered by Academician Shen Yinchu in the 1980s, eliminated the need for copper catalysts and enabled the large-scale, energy-efficient production of polyacrylamide for water treatment and oil extraction.
Key Innovations Driving Industrial Transformation:
- Microbial Cell Factories: Engineered strains, such as E. coli and yeast, are optimized to produce high-value compounds. For instance, L-methionine, an essential amino acid with a global demand of 1.7 million tons and a market value of ¥33 billion, can be produced this way. Zheng Yuguo’s team developed a fermentation-enzyme coupling system yielding 140 g/L of precursor (OSH) with 80% sugar-acid conversion, setting an international benchmark.
- Enzyme-Catalyzed Processes: Jiangsu Limin’s “gas-phase synthesis—multi-enzyme cascade” technology for producing L-glufosinate achieves over 99% yield and 100% optical purity. This technology outperforms chemical synthesis in terms of cost and sustainability.
- Hybrid Chemo-Bio Routes: Insulin and atorvastatin calcium are now produced via integrated chemical-enzymatic methods that combine the precision of synthetic biology with the scalability of traditional chemistry.
Economic Potential and Global Impact
The synthetic biology market reached $17 billion in 2023, growing at a rate of 28.8% annually. It is projected to generate trillions of dollars in economic value by the year 2100. In China, initiatives such as the “Yangtze River Delta Synthetic Biomanufacturing Corridor” have already spurred the development of a 100 billion yuan industrial cluster, with further expansions underway.
Policy and Collaborative Frameworks
Governments around the world are prioritizing synthetic biomanufacturing. For example, China’s 14th Five-Year Plan for the bioeconomy emphasizes using industrial biotechnology to decarbonize chemicals, materials, and energy. The U.S. Bioeconomy Executive Order (2022) aims to produce 30% of chemicals via biomanufacturing by 2043. The EU’s Industrial Biotechnology Roadmap aims to substitute 25% of chemicals with bio-based alternatives by 2030. Public-private partnerships, such as the Zhejiang University Industry Innovation Centers and the National Innovation Center for Biotechnology in Suzhou Industrial Park, are accelerating the translation of research and development. The park’s 2025–2027 biomanufacturing action plan aims to nurture five leading enterprises and 150 high-growth firms, targeting 15 billion yuan in output.
Challenges and Future Directions
Despite the progress made, there are still some hurdles. Scalability is an issue because non-model microbial hosts (e.g., Halomonas) require customized genetic tools for industrial use. Cost-effectiveness is also a challenge. As Academician Ma Dawei notes, synthetic biology must target high-volume inputs, such as pesticides and feed additives. Furthermore, convergence with AI is essential because machine learning is crucial for strain optimization and pathway design.
Conclusion:
Synthetic biomanufacturing is more than just a technological upgrade; it is a fundamental restructuring of industrial systems. By decoupling production from fossil fuels, minimizing waste, and enabling circular economies, synthetic biomanufacturing embodies “green productivity,” which is central to China’s new strategy of quality productive forces. Synthetic biomanufacturing is leading the way in the Fourth Industrial Revolution and has the potential to bring about significant changes in our world.
